These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 871863)

  • 21. Acetylation phenotype in colorectal carcinoma.
    Ilett KF; David BM; Detchon P; Castleden WM; Kwa R
    Cancer Res; 1987 Mar; 47(5):1466-9. PubMed ID: 3815349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of the acetylator phenotype in a Northern Nigerian population.
    Fawcett IW; Gammon PT
    Tubercle; 1975 Sep; 56(3):199-201. PubMed ID: 1216338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simplified micromethod for the determination of the acetylator phenotype.
    Hoo JJ; Hussein L; Goedde HW
    J Clin Chem Clin Biochem; 1977 Jun; 15(6):329-31. PubMed ID: 894203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic acetylator phenotype in diabetes mellitus.
    Ladero JM; Arrojo A; de Salamanca RE; Gomez M; Cano F; Alfonso M
    Ann Clin Res; 1982 Aug; 14(4):187-9. PubMed ID: 7168549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The acetylator phenotypes of Saudi Arabian diabetics.
    Evans DA; Paterson S; Francisco P; Alvarez G
    J Med Genet; 1985 Dec; 22(6):479-83. PubMed ID: 4078878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulphamethoxazole acetylation in fast and slow acetylators.
    Bozkurt A; Basci NE; Isimer A; Tuncer M; Erdal R; Kayaalp SO
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):164-6. PubMed ID: 2338369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetylator polymorphism in Alzheimer's disease.
    Ladero JM; Barquero MS; Coria F; Molina JA; Jiménez-Jiménez FJ; Benítez J
    Eur J Med; 1993 May; 2(5):281-3. PubMed ID: 8252158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphically acetylated aminoglutethimide in humans.
    Coombes RC; Foster AB; Harland SJ; Jarman M; Nice EC
    Br J Cancer; 1982 Sep; 46(3):340-5. PubMed ID: 7126424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acetylation phenotype as a risk factor of diabetic neuropathy].
    Miarka J; Jonderko G; Straszecka J; Lachowicz B
    Przegl Lek; 1990; 47(4):385-8. PubMed ID: 2217853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetylation phenotype in hypertensive patients.
    Huang CY; Chu JY; Yen TC
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Jan; 8(1):1-5. PubMed ID: 1548734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphic N-acetylation of sulfamethazine and benzidine by human liver: implication for cancer risk?
    Peters JH; Gordon GR; Lin E; Green CE; Tyson CA
    Anticancer Res; 1990; 10(1):225-9. PubMed ID: 2334132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-acetylation phenotyping with sulfamethazine in an Iranian population.
    Sardaş S; Lahijany B; Cok I; Karakaya AE
    Pharmacogenetics; 1993 Jun; 3(3):131-4. PubMed ID: 8334437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
    Singh SP; Pande JN; Khilnani GC; Kailash S
    Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
    Ellard GA
    Rev Mal Respir; 1984; 1(4):207-19. PubMed ID: 6505358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphic acetylation of sulphamethazine in man: acetylator phenotype in sicklers and non-sicklers.
    Jeyakumar LH; French MR
    Toxicol Lett; 1980 Sep; 6(4-5):263-5. PubMed ID: 7423555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of acetaminophen on sulfamethazine acetylation in male volunteers.
    Tahir IM; Iqbal T; Saleem S; Mehboob H; Akhter N; Riaz M
    Int J Immunopathol Pharmacol; 2016 Mar; 29(1):17-22. PubMed ID: 26519524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acetylation phenotype in patients with lung cancer].
    Cofta S; Lowicki Z; Młynarczyk W
    Pneumonol Alergol Pol; 1995; 63(7-8):407-9. PubMed ID: 8520558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The examination of apoE phenotypes in diabetic patients with peripheral neuropathy].
    Tsuzuki S; Murano T; Watanabe H; Itoh Y; Miyashita Y; Shirai K
    Rinsho Byori; 1998 Aug; 46(8):829-33. PubMed ID: 9760837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening methods using sulfamethazine for determining acetylator phenotype.
    du Souich P; McLean AJ; Stoeckel K; Ohlendorf D; Gibaldi M
    Clin Pharmacol Ther; 1979 Dec; 26(6):757-65. PubMed ID: 498718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological evidence for N-acetyltransferase isozymes in the rabbit.
    Reeves PT; Kinnear BF; Minchin RF; Ilett KF
    Mol Pharmacol; 1991 Jan; 39(1):42-8. PubMed ID: 1987451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.